Focusing on "AI+Drug Delivery", DynaTech Pharmaceuticals Closes $100 Million Series C Funding Round
METiS Pharmaceuticals, an innovative biotech company specializing in "AI+drug delivery", announced the completion of its US$100 million Series C financing round, led by CICC Capital's fund and followed by China Taiping's Taiping Hong Kong Insurance Science and Technology Fund. Together with this...
简体中文 
English